BMY

Bristol-Myers Squibb
D

BMY

Arincen68/100B

Bristol-Myers Squibb net income 1987–2026

Bristol-Myers Squibb earned 2.16B USD in Q3 FY2026, the three months to 30 September 2026, down 1.8% on the same quarter a year before. Bristol-Myers Squibb's net income over the last twelve months was 9.24B USD, up 53.1% on the twelve months before. In fiscal year 2025 it earned 7.05B USD, against a loss of 8.95B USD on the year before.

Last updated 12 Nov 2026 · Next report 4 Feb 2027

Net income

Net income · +16.2% a year over 10 yearsNet margin

Growth

Fiscal yearPeriod endingNet incomeGrowthNet marginRevenue
TTM30 Sept 20269.24B+53.06%18.47%50.03B
FY202531 Dec 20257.05B—14.64%48.20B
FY202431 Dec 2024-8.95B-211.50%-18.53%48.30B
FY202331 Dec 20238.03B+26.84%17.83%45.01B
FY202231 Dec 20226.33B-9.54%13.71%46.16B
FY202131 Dec 20216.99B—15.08%46.39B
FY202031 Dec 2020-9.02B-362.14%-21.20%42.52B
FY201931 Dec 20193.44B-30.10%13.15%26.15B
FY201831 Dec 20184.92B+388.58%21.81%22.56B
FY201731 Dec 20171.01B-77.41%4.85%20.78B
FY201631 Dec 20164.46B+184.79%22.94%19.43B
FY201531 Dec 20151.57B-21.91%9.45%16.56B
FY201431 Dec 20142.00B-21.81%12.62%15.88B
FY201331 Dec 20132.56B+30.77%15.64%16.39B
FY201231 Dec 20121.96B-47.16%11.12%17.62B
FY201131 Dec 20113.71B+19.57%17.46%21.24B
FY201031 Dec 20103.10B-70.77%15.92%19.48B
FY200931 Dec 200910.61B+102.25%56.42%18.81B
FY200831 Dec 20085.25B+142.36%25.47%20.60B
FY200731 Dec 20072.17B+36.59%11.19%19.35B
FY200631 Dec 20061.59B-47.17%8.85%17.91B
FY200531 Dec 20053.00B+25.63%15.62%19.21B
FY200431 Dec 20042.39B-23.12%12.32%19.38B
FY200331 Dec 20033.11B+45.34%14.87%20.89B
FY200231 Dec 20022.14B-55.79%11.79%18.12B
FY200131 Dec 20014.83B+2.61%24.89%19.42B
FY200031 Dec 20004.71B+13.05%25.86%18.22B
FY199931 Dec 19994.17B+32.66%20.61%20.22B
FY199831 Dec 19983.14B-2.00%17.18%18.28B
FY199731 Dec 19973.21B+12.46%19.19%16.70B
FY199631 Dec 19962.85B+57.28%18.92%15.07B
FY199531 Dec 19951.81B-1.63%13.16%13.77B
FY199431 Dec 19941.84B-5.97%15.37%11.98B
FY199331 Dec 19931.96B-0.15%17.16%11.41B
FY199231 Dec 19921.96B-4.57%17.59%11.16B
FY199131 Dec 19912.06B+17.62%18.42%11.16B
FY199031 Dec 19901.75B+134.00%16.97%10.30B
FY198931 Dec 1989747.00M-40.43%8.13%9.19B
FY198831 Dec 19881.25B+17.42%14.65%8.56B
FY198731 Dec 19871.07B—14.13%7.56B

Figures in USD. Shares and EPS are adjusted for stock splits. Quarterly growth is on the same quarter a year before; TTM is the last four quarters.

See also:Revenue,EPS,Shares outstanding,Operating income,Cash on hand,Total debt,Free cash flow,Stock buybacks,Income statement

Common questions about Bristol-Myers Squibb's profit

Source: Financial Modeling PrepVerified against SEC filings